PETALING JAYA: The health, science and innovation parliamentary select committee (PSC) says that the quantum of fines under Act 342 of the Prevention and Control of Infectious Diseases Act 1988, especially for corporate bodies, was one of the issues that would be further discussed and benchmarked proportionately with best practices all around the world.
Committee chairman Dr Kelvin Yii said that the quantum chosen by the government has to be justified and benchmarked against practices of other countries, as well as data to justify the higher fines and whether it will increase compliance.
